Prognostic Impact of Postoperative Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.

新辅助治疗 放化疗 食管切除术 存活率 阶段(地层学) 食管癌 淋巴血管侵犯 放射治疗 食管鳞状细胞癌 淋巴 倾向得分匹配 回顾性队列研究 放射科 比例危险模型 外科
作者
Xuefeng Leng,Wenwu He,Hong Yang,Yuping Chen,Chengchu Zhu,Wentao Fang,Zhentao Yu,Weimin Mao,Jiaqing Xiang,Zhijian Chen,Haihua Yang,Jiaming Wang,Qingsong Pang,Xiao Zheng,Hui Liu,H. Yang,Tao Li,Xu Zhang,Qun Li,Geng Wang,Teng Mao,Xufeng Guo,Ting Lin,Mengzhong Liu,Jianhua Fu,Yongtao Han
出处
期刊:Annals of Surgery [Lippincott Williams & Wilkins]
卷期号:274 (6) 被引量:21
标识
DOI:10.1097/sla.0000000000003727
摘要

Objective To determine the prognostic impact of pathologic lymph node (LN) status and investigate risk factors of recurrence in esophageal squamous cell carcinoma (ESCC) patients with pathologic complete response (pCR) after neoadjuvant chemoradiotherapy (NCRT). Summary background data There are no large-scale prospective study data regarding ypN status and recurrence after pCR in ESCC patients receiving NCRT. Methods The NEOCRTEC5010 trial was a prospective multicenter trial that compared the survival and safety of NCRT plus surgery (S) with S in patients with locally advanced ESCC. The relationships between survival and cN, pN, and ypN status were assessed. Potential prognostic factors in patients with ypN+ and pCR were identified. Results A total of 389 ESCC patients (NCRT: 182; S: 207) were included. Patients with pN+ in the S group and ypN+ in the NCRT group had decreased overall survival (OS) and disease-free survival (DFS) compared with pN0 and ypN0 patients, respectively. Partial response at the primary site [hazard ratio (HR), 2.09] and stable disease in the LNs (HR, 3.26) were independent risk factors for lower DFS, but not OS. For patients with pCR, the recurrence rate was 13.9%. Patients with distant LN metastasis had a median OS and DFS of 16.1 months and 14.4 months, respectively. Failure to achieve the median total dose of chemotherapy was a significant risk factor of recurrence and metastasis after pCR (HR, 44.27). Conclusions Persistent pathologic LN metastasis after NCRT is a strong poor prognostic factor in ESCC. Additionally, pCR does not guarantee a cure; patients with pCR should undergo an active strategy of surveillance and adjuvant therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ZZZ完成签到,获得积分10
1秒前
栗子完成签到 ,获得积分10
3秒前
等待的盼波完成签到,获得积分10
3秒前
CAOHOU应助嘟嘟请让一让采纳,获得10
3秒前
3秒前
天天向上完成签到,获得积分10
3秒前
野原小龙虾完成签到,获得积分10
4秒前
time完成签到,获得积分10
4秒前
4秒前
阿绿发布了新的文献求助10
8秒前
9秒前
9秒前
雨柏完成签到 ,获得积分10
9秒前
wanci应助qwe1108采纳,获得10
10秒前
明天过后完成签到,获得积分10
12秒前
jin完成签到,获得积分10
13秒前
yhy完成签到 ,获得积分10
14秒前
黑色卡布奇诺完成签到,获得积分20
14秒前
tanglu发布了新的文献求助10
14秒前
可爱的函函应助梁大海采纳,获得10
14秒前
成就绮琴完成签到 ,获得积分10
15秒前
xicifish完成签到,获得积分10
15秒前
目光之澄完成签到,获得积分10
16秒前
wanci应助研友_ndDPBn采纳,获得10
16秒前
耍酷的白梦完成签到,获得积分10
17秒前
miracle完成签到 ,获得积分10
18秒前
coding完成签到,获得积分10
19秒前
20秒前
犹豫水蓝完成签到,获得积分10
21秒前
yin完成签到,获得积分10
21秒前
JUGG完成签到,获得积分10
21秒前
CipherSage应助阿湫采纳,获得10
22秒前
FIN应助手机采纳,获得20
22秒前
星辰大海应助东黎采纳,获得10
22秒前
量子星尘发布了新的文献求助10
22秒前
wujingshuai完成签到,获得积分10
23秒前
少年完成签到,获得积分10
23秒前
星辰大海应助ficus_min采纳,获得10
24秒前
小柒柒完成签到,获得积分10
25秒前
sdfwsdfsd完成签到,获得积分10
26秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038524
求助须知:如何正确求助?哪些是违规求助? 3576221
关于积分的说明 11374737
捐赠科研通 3305912
什么是DOI,文献DOI怎么找? 1819354
邀请新用户注册赠送积分活动 892688
科研通“疑难数据库(出版商)”最低求助积分说明 815048